Swedish medtech start-up company Capitainer on Wednesday announced a collaboration with the University of Florida to accelerate the method development for Capitainer’s quantitative dried blood spot (qDBS)-sampling technology.
The collaboration aims to accelerate the development of laboratory tools needed to address a shortage of clinical laboratories and methods for at-home collection of microsamples, the company said.
The collaboration is with the Timothy J. Garrett Laboratory at the College of Medicine, University of Florida.
Financial and other terms of the collaboration were not disclosed.
